Spots Global Cancer Trial Database for A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat
Official Title: A Disease Registry Encompassing the Care of Patients With Multiple Myeloma on Panobinostat (RECOMM)
Study ID: NCT04150289
Conditions
Interventions
Study Description
Brief Summary: This study aims to describe current treatment patterns in the real-world setting among patients with multiple myeloma who are initiating treatment with (or changing treatment to) panobinostat and explore the associations with baseline patient characteristics, healthcare resource utilization, and clinical outcomes.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
American Health Network Indiana, Indianapolis, Indiana, United States
Southern Nevada Cancer Research Foundation and Optum Cancer Care, Las Vegas, Nevada, United States
Oncology Specialists of Charlotte, Charlotte, North Carolina, United States
Southern Oncology Specialists, Huntersville, North Carolina, United States
Gettysburg Cancer Center, Gettysburg, Pennsylvania, United States
Coastal Cancer Center, Myrtle Beach, South Carolina, United States
Carolina Blood and Cancer Care Associates, Rock Hill, South Carolina, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
